Ownership history in BB BIOTECH AG · 4 quarters on record
This page tracks every 13F SEC filing in which BB BIOTECH AG reported a position in Myokardia Inc. (MYOK). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2019 Q1 | ADDED | 1,264,913 | +387,647 | +44.2% | 1.65% | $65.8M | — |
| 2018 Q4 | ADDED | 877,266 | +367,266 | +72.0% | 1.37% | $42.9M | — |
| 2018 Q3 | ADDED | 510,000 | +30,000 | +6.2% | 0.88% | $33.3M | — |
| 2018 Q2 | INITIATED | 480,000 | — | — | 0.69% | $23.8M | — |